Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 24, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	177	110	67	203	37	14
Market Cap Growth	-6.20%	64.77%	-66.97%	445.88%	158.90%	148.91%
Enterprise Value	104	17	-50	63	29	-0
Last Close Price	1.46	0.88	0.53	1.60	0.95	1.57
PE Ratio	-	-3.69	-2.48	-9.08	-0.48	-0.77
PB Ratio	2.29	1.21	0.57	1.47	1.37	1.09
P/FCF Ratio	-8.01	-5.26	-3.22	-12.29	-3.21	-1.57
P/OCF Ratio	-8.01	-5.27	-3.22	-12.30	-3.21	-1.57
EV/EBITDA Ratio	-2.15	-0.54	1.80	-3.08	-1.97	0.01
EV/EBIT Ratio	-2.15	-0.54	1.80	-3.08	-1.96	0.01
EV/FCF Ratio	-3.51	-0.80	2.40	-3.83	-2.48	0.02
Debt / Equity Ratio	-	-	-	-	0.00	0.00
Debt / FCF Ratio	-	-	-	-	0.00	-0.01
Quick Ratio	13.96	16.89	20.05	43.97	2.56	10.07
Current Ratio	14.35	17.61	21.23	45.18	2.73	10.83
Return on Equity (ROE)	-28.00%	-28.80%	-21.05%	-24.93%	-88.42%	-157.00%
Return on Assets (ROA)	-19.68%	-17.85%	-13.07%	-13.93%	-31.85%	-82.34%
Return on Capital (ROIC)	-20.65%	-18.77%	-13.52%	-15.52%	-45.20%	-98.05%
Earnings Yield	-14.11%	-27.29%	-40.29%	-10.17%	-48.04%	-120.26%
FCF Yield	-10.18%	-19.00%	-31.06%	-8.13%	-31.20%	-63.73%
Buyback Yield / Dilution	0.86%	0.43%	-8.27%	-934.13%	-33.09%	-104.36%
Total Shareholder Return	0.86%	0.43%	-8.27%	-934.13%	-33.09%	-104.36%

Source: S&P Capital IQ. Standard template. Financial Sources.